These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6502004)

  • 1. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults.
    Takahashi H; Oishi K; Yoshimine H; Kumatori A; Moji K; Watanabe K; Nalwoga H; Tugume SB; Kebba A; Mugerwa R; Mugyenyi P; Nagatake T
    Clin Infect Dis; 2003 Dec; 37(11):1534-40. PubMed ID: 14614677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region.
    Fischetti VA
    J Immunol; 1983 Feb; 130(2):896-902. PubMed ID: 6336773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody inhibition of polymorphonuclear phagocytosis. Dissociation of bacterial attachment and bacterial killing.
    Crowley JP; Valeri CR
    J Lab Clin Med; 1980 Jun; 95(6):868-76. PubMed ID: 7381296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR; Augustine NH; Shigeoka AO
    Am J Med; 1984 Mar; 76(3A):61-6. PubMed ID: 6424458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonins in human serum for the phagocytosis of complexes between IgG and protein A of Staphylococcus aureus.
    Hällgren R; Stålenheim G
    Immunology; 1978 Jul; 35(1):13-20. PubMed ID: 680797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
    Fick RB; Reynolds HY
    Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovine opsonins for Staphylococcus aureus cell wall and pseudocapsule.
    Watson DL
    Res Vet Sci; 1989 Jan; 46(1):84-9. PubMed ID: 2784216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
    Anthony BF; Concepcion NF
    Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro.
    Hof DG; Repine JE; Peterson PK; Hoidal JR
    Am Rev Respir Dis; 1980 Jan; 121(1):65-71. PubMed ID: 7352714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum opsonic activity in rodent malaria: functional and immunochemical characteristics in vitro.
    Hunter KW; Winkelstein JA; Simpson TW
    J Immunol; 1979 Dec; 123(6):2582-7. PubMed ID: 387873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of Staphylococcus aureus by bovine immunoglobulin isotypes.
    Guidry AJ; Berning LM; Hambleton CN
    J Dairy Sci; 1993 May; 76(5):1285-9. PubMed ID: 8505420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF; Yang KD; Bohnsack JF; Hill HR
    Pediatr Res; 1989 Jun; 25(6):634-40. PubMed ID: 2662129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of intravenous immunoglobulin supplementation on serum opsonic activity in tracheostomised patients.
    Chandra RS; Dandekar UP; Karnard D; Tilve GH; Kshirsagar NA
    Indian J Med Res; 1992 Apr; 96():109-11. PubMed ID: 1428049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.